β-carotene-loaded nanoparticles protect against neuromotor damage, oxidative stress, and dopamine deficits in a model of Parkinson's disease in Drosophila melanogaster

Comp Biochem Physiol C Toxicol Pharmacol. 2023 Jun:268:109615. doi: 10.1016/j.cbpc.2023.109615. Epub 2023 Mar 20.

Abstract

β-carotene-loaded nanoparticles improves absorption by increasing bioavailability. The Drosophila melanogaster model of Parkinson's disease must be helpful in investigating potential neuroprotective effects. Four groups of four-day-old flies were exposed to: (1) control; (2) diet containing rotenone (500 μM); (3) β-carotene-loaded nanoparticles (20 μM); (4) β-carotene-loaded nanoparticles and rotenone for 7 days. Then, the percentage of survival, geotaxis tests, open field, aversive phototaxis and food consumption were evaluated. At the end of the behaviors, the analyses of the levels of reactive species (ROS), thiobarbituric acid reactive substances (TBARS), catalase (CAT) and superoxide dismutase (SOD) activity was carried out, as well as an evaluation of the levels of dopamine and acetylcholinesterase (AChE) activity, in the head of flies. Nanoparticles loaded with β-carotene were able to improve motor function, memory, survival and also restored the oxidative stress indicators (CAT, SOD, ROS and TBARS), dopamine levels, AChE activity after exposure to rotenone. Overall, nanoparticles loaded with β-carotene showed significant neuroprotective effect against damage induced by the Parkinson-like disease model, emerging as a possible treatment. Overall, β-carotene-loaded nanoparticles presented significant neuroprotective effect against damage induced by model of Parkinson-like disease, emerging as a possible treatment.

Keywords: Antioxidant; Carotenoids; Nanoencapsulation; Neurodegeneration; Neuroprotective.

MeSH terms

  • Acetylcholinesterase / metabolism
  • Animals
  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Disease Models, Animal
  • Dopamine
  • Drosophila melanogaster
  • Nanoparticles*
  • Neuroprotective Agents* / pharmacology
  • Oxidative Stress
  • Parkinson Disease* / drug therapy
  • Parkinson Disease* / prevention & control
  • Reactive Oxygen Species
  • Rotenone
  • Superoxide Dismutase / metabolism
  • Thiobarbituric Acid Reactive Substances
  • beta Carotene / pharmacology

Substances

  • beta Carotene
  • Antioxidants
  • Dopamine
  • Rotenone
  • Reactive Oxygen Species
  • Neuroprotective Agents
  • Thiobarbituric Acid Reactive Substances
  • Acetylcholinesterase
  • Superoxide Dismutase